
Przedsiębiorstwo Farmaceutyczne Farmapol sp. z o.o.
Manufacture of pharmaceutical preparations
Overview
Przedsiębiorstwo Farmaceutyczne Farmapol is a company that manufactures medications, dietary supplements, and cosmetics. They offer a range of products aimed at health and beauty, including over-the-counter and prescription medications, as well as specific formulations like ASMAG® and ZINCAS®. Their focus includes skin care, muscle health, and immune support.
Financials
Revenue history (in m)
From the notes
| Current income tax (CIT due) | $1,617,728 |
Filing timeliness
Financial statements were filed on time, on average 77 days early. All were audited by a statutory auditor.
- 202510/06/2026
- 202405/05/2025
- 202310/05/2024
- 202210/05/2023
- 202110/05/2022
- 202011/05/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Offer
- Medicines
- Dietary supplements
- Facial cosmetics
- Hand creams
- Body lotions
- Care gels
- Lip balms
Websites
- farmapol.plFarmapol – leki, suplementy diety i kosmetykiWooCommerce 9.7WordPress 7.1PPayUGoogle Tag ManagerYoast SEOCloudflareApache
- asmagb6forte.plAsmag® B6 Forte – polski lek z magnezem i witaminą B6 w tabletkachWordPressGoogle Tag ManagerYoast SEOApache
Trademarks
The company holds 16 active trademarks registered with the Polish Patent Office. 11 applications are pending. The first mark was filed in 1993.
| Mark | Protected until | |
|---|---|---|
| Farmapol | Jul 10, 2035 | |
| Mark without a word element (figurative) | Jul 10, 2035 | |
| FARMAPOL (word) | Jul 10, 2035 | |
| Cremobaza | Sep 27, 2031 | |
| HERBA STUDIO | Aug 2, 2033 |
Authorized Representatives
Manner of representation
For the submission of declarations of will and entering into liabilities on behalf of the company, as well as for performing other legal acts transferring rights with a value exceeding PLN 100,000, the joint declaration of two members of the management board is required. Each member of the management board may independently submit declarations or undertake liabilities up to PLN 100,000. If the management board is multi-member, the joint action of two members of the management board or of one member of the management board jointly with a commercial proxy is required for the submission of declarations on behalf of the company concerning non-property matters (including the submission of registration applications), in accordance with Article 205 § 1 of the Commercial Companies Code.
Supervisory board
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Kinga Rybka-Knast age 59 | 5,409 | $73,055.11 | 13.5225% |
Barbara Szematowicz age 73 | 8,080 | $109,130.20 | 20.2% |
Others | 26,511 | $358,063.21 | 66.2775% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2003-12-31.
54 1160 2202 0000 0004 8413 4398
07 1160 2202 0000 0004 8413 4565
40 1160 2202 0000 0000 6089 3095
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Land (incl. perpetual usufruct) | $45,452$45,452 |
Buildings and premises | $686.1K$686,137 |
Public aid
21 public aid cases recorded, with a total value of $462,795.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Feb 11, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $26,118$26,118 | Prezes Banku Gospodarstwa Krajowego | |
| Sep 6, 2024 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $1,683$1,683 | Prezes Banku Gospodarstwa Krajowego | |
| Sep 6, 2024 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $884$884 | Prezes Banku Gospodarstwa Krajowego |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2019-10-31 | Research and development work on the new Asmag B6 FORTE medicine | $108.9K$108,945 | Wielkopolska Regional Operational Programme for 2014 – 2020 |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Wörwag Pharma Operations sp. z o.o. | $46,828,794.87 | woerwagpharma.pl | ||
| Phytopharm Klęka S.A. | $46,154,888.31 | phytopharm.pl | ||
| Poznańskie Zakłady Zielarskie Herbapol S.A. | $31,668,225.77 | herbapol.poznan.pl | ||
| Zakłady Farmaceutyczne Colfarm S.A. | $27,692,749.78 | colfarm.pl | ||
| Exim Pharma sp. z o.o. | $24,694,130.27 | eximpharma.eu | ||
| Aristo Pharma sp. z o.o. | $22,775,627.72 | aristo-pharma.pl | ||
| Przedsiębiorstwo Produkcyjno-Handlowe Ewa S.A. | $14,322,437.53 | ewa-sa.pl | ||
| Wellmedica Hf sp. z o.o. | $8,037,044.71 | wellmedica.pl | ||
| Ethifarm sp. z o.o. + limited partnership | $5,691,422.61 | ethifarm.pl | ||
| Adpharma sp. z o.o. | $5,595,917.60 | adamed.com |
Change history
| Date | Event | |
|---|---|---|
| 2022-05-13 | Address change (Św. Wojciech 29, 61-749, Poznań → Ul. Święty Wojciech 29, 61-749, Poznań) | |
| 2022-05-13 | Name change (Przedsiębiorstwo Farmaceutyczne "farmapol" → Przedsiębiorstwo Farmaceutyczne Farmapol) | |
| 2021-09-22 | Name change (Przesiębiorstwo Farmaceutyczne "farmapol" → Przedsiębiorstwo Farmaceutyczne "farmapol") | |
| 2021-06-29 | Name change (Zakład Chemiczno - Farmaceutyczny "farmapol" → Przesiębiorstwo Farmaceutyczne "farmapol") | |
| 2002-06-18 | Share capital increase (200,000.00 PLN → 2,000,000.00 PLN) |
FAQ
Last updated: 2026-06-12